NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: STEMCELL Technologies, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

STEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award - STEMCELL Technologies, Canada’s largest biotechnology company, has received the Canada's Most Admired Corporate Cultures™ of 2023 award by Waterstone Human Capital - WaterstoneHC.com / STEMCELL.com
STEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award

 

NewswireTODAY - /newswire/ - Vancouver, British Columbia, Canada, 2023/11/23 - STEMCELL Technologies, Canada’s largest biotechnology company, has received the Canada's Most Admired Corporate Cultures™ of 2023 award by Waterstone Human Capital - WaterstoneHC.com / STEMCELL.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

This national awards program recognizes best-in-class Canadian organizations for fostering high-performance corporate cultures that help sustain a competitive advantage.

“Being named to Waterstone’s list of Canada’s Most Admired Corporate Cultures™ is a testament to the human-centered approach that every STEMCELL colleague brings to their role,” said Helen Sheridan, Chief Human Resources Officer, STEMCELL. “Our diverse and dynamic team of over 2,400 employees has always been guided by our five core values of innovation, responsiveness, quality, collaboration, and integrity; this award is a welcome acknowledgment that our team sees that living these values has been key to our success over the past 30 years.”

In addition to being included on Waterstone Human Capital’s list of Canada’s Most Admired Corporate Cultures™, STEMCELL recently received the Company of the Year Anchor Award at the 2023 Technology Impact Awards, which recognizes outstanding employers in British Columbia. In 2023, STEMCELL was also named one of Canada’s Best Managed Companies by Deloitte and recognized as an I.D.E.A.L. Bioscience Employer by BioTalent Canada.

“STEMCELL’s corporate culture is a reflection of our people. Delivering on our commitments as Scientists Helping Scientists simply would not be possible without creating an environment that attracts the best and brightest talent,” said Dr. Allen Eaves, President and CEO, STEMCELL. “Innovation and advancing science are at the heart of everything we do and we are proud to provide a rewarding, inclusive, and enriching culture that enables STEMCELL colleagues to achieve their full potential.”

About STEMCELL Technologies

STEMCELL Technologies (stemcell.com) supports life sciences research with more than 2,500 specialized reagents, tools, and services. STEMCELL offers high-quality cell culture media, cell separation technologies, instruments, accessory products, educational resources, and contract assay services that are used by scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research globally.

About Waterstone Human Capital

Founded in 2003, Waterstone Human Capital (waterstonehc.com) is a leading cultural talent management professional services firm for organizations across North America that see culture as their single greatest asset. Their team of leadership advisors provides services designed to meet clients’ leadership training, recruitment, and culture and engagement measurement and assessment needs.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: STEMCELL Technologies, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


STEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Waterstone Human Capital | STEMCELL
Contact: Ryan-Sang Lee - STEMCELL.com 
+1 800-667-0322 public.relations[.]stemcell.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any STEMCELL Technologies, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From STEMCELL Technologies, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ono Pharma Enters into a Drug Discovery Partnership with Mediar Therapeutics to Create Novel Antibody Therapeutics for Fibro-inflammatory Diseases
OPDIVO® Intravenous Infusion Approved in South Korea for the Treatment of Resectable Non-Small Cell Lung Cancer
Ipsen Completes Acquisition of Memo Therapeutics AG, Adding First-in-class Asset to Ipsen’s Rare Disease Pipeline
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
IQIRVO® Demonstrates Statistically Significant Improvement in ALP Normalization in Patients with PBC in Phase IIIb ELSPIRE Study
Dysport® is the First Botulinum Toxin to Achieve Positive Topline Phase III Results in Both Episodic and Chronic Migraine
STEMCELL Technologies and CCRM Partner to Expand Access to Matched GMP and RUO iPSC Lines for Cell Therapy Development
Ipsen to Acquire Memo Therapeutics AG - Adding First-in-class BK Polyomavirus Antibody, Expanding Rare Disease Portfolio
Ipsen to Acquire Kartos Therapeutics, Expanding Hemato-oncology Late-stage Pipeline
Ono Pharma Submits a Supplemental Application in Japan to Expand the Use of VELEXBRU® Tablets for the Treatment of Central Nervous System Involvement
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 in Multiple System Atrophy At the 7th World Parkinson Con
Ipsen Announces Late-breaking Data from First Head-to-head Study Comparing Dysport® and Botox® in Adults with Upper Limb Spasticity
Ipsen Unveils Corabotase, A First-in-class Recombinant Neuroinhibitor, RNI™ At the SCALE Symposium
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with CartriQ® BioPure
Ojemda® Approved in The European Union as the First Targeted Therapy in Relapsed or Refractory Pediatric Low-grade Glioma

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit BizJobs.com





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)